Dermira Presents Data From DRM01 Phase 2a Trial at European Academy of Dermatology and Venereology
07. Oktober 2015 07:30 ET
|
Dermira, Inc.
MENLO PARK, Calif., Oct. 7, 2015 (GLOBE NEWSWIRE) -- Dermira, Inc. (NASDAQ:DERM), a specialty biopharmaceutical company focused on bringing innovative and differentiated products to dermatologists and...
Dermira Announces Poster Presentation on DRM01 in Acne at World Congress of Dermatology
02. Juni 2015 07:30 ET
|
Dermira, Inc.
MENLO PARK, Calif., June 2, 2015 (GLOBE NEWSWIRE) -- Dermira, Inc. (Nasdaq:DERM), a specialty biopharmaceutical company focused on bringing innovative and differentiated products to dermatologists and...
Clinical Data for Dermira's DRM01 Acne Program Presented at Dermatology Meeting
23. März 2015 07:00 ET
|
Dermira, Inc.
MENLO PARK, Calif., March 23, 2015 (GLOBE NEWSWIRE) -- Dermira, Inc. (Nasdaq:DERM), a specialty biopharmaceutical company focused on bringing innovative and differentiated products to dermatologists...